December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Gene Therapy with the ND4 Subunit Gene Re-coded in the Universal Genetic Code Rescues a Mitochondrial Deficiency Causing Leber Hereditary Optic Neuropathy
Author Affiliations & Notes
  • J Guy
    Ophthalmology
    University of Florida Gainesville FL
  • A Lewin
    University of Florida Gainesville FL
  • X Qi
    Ophthalmology
    University of Florida Gainesville FL
  • W Hauswirth
    Ophthalmology
    University of Florida Gainesville FL
  • Footnotes
    Commercial Relationships   J. Guy, None; A. Lewin, None; X. Qi, None; W. Hauswirth, None. Grant Identification: EY 12355
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4599. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J Guy, A Lewin, X Qi, W Hauswirth; Gene Therapy with the ND4 Subunit Gene Re-coded in the Universal Genetic Code Rescues a Mitochondrial Deficiency Causing Leber Hereditary Optic Neuropathy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4599.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To rescue a deficiency in oxidative phosphorylation to a cybrid cell line harboring the G11778A LHON mutation in mitochondrial DNA. Methods: Cybrid cell lines created from patient's tissue with the LHON G11778A mitochondrial DNA mutation in a normal nuclear background showed a 60% reduction in the rate of ATP synthesis. To overcome this deficiency, we re-coded the entire ND4 subunit of mtDNA using the universal genetic code, imported the translated protein into the mitochondria with a mitochondrial targeting sequence (allotopic expression) derived from the P1 isoform of subunit c of ATP synthase (ATPc). For detection of import a FLAG epitope tag was added at the C-terminus. The P1ND4F fusion gene was inserted in an adeno-associated viral(AAV) vector and LHON cybrid cells were transfected. Cells were grown in glucose-rich media, then placed in glucose-free medium containing galactose as the main carbon source for glycolysis. This medium forces the cells to rely predominantly on oxidative phosphorylation to produce ATP. Cells harboring complex I mutations have a severe growth defect in galactose medium. Results: FLAG immunocytochemistry revealed a typical punctate mitochondrial pattern that co-localized with the mitochondrion-specific dye MitoTracker Red, suggesting that P1ND4F was localized in mitochondria. Western blot analysis showed the imported P1ND4F fusion protein of a size consistent with that of the imported polypeptide. Cell survival after 3 days in the glucose deficient galactose media was 3-fold greater for the allotopically transfected P1ND4F cybrids than mock-transfected cybrids (p<0.005). Assays of complex I activity in whole cells by the reduction of cytochrome c with NADH revealed no significant reduction in G11778A cybrids compared to wild-type cybrids. Therefore, we focused on changes in ATP synthesis using the complex I substrates malate and pyruvate. Relative to the wild-type cell line, G11778A mutant cybrids showed a 60% reduction in the rate of ATP synthesis. Allotopic expression of ND4 reversed this deficiency in ATP synthesis. Relative to mock-transfected cybrids, G11778A cybrids complemented with P1ND4F showed a 3-fold increase in the rate of ATP synthesis (p=0.02). In fact, this degree of recovery lead to rates of ATP synthesis that were virtually indistinguishable from the corresponding wild-type cell line. Conclusions: Restoration of ATP synthesis to a cell line harboring the LHON G11778A mutation by allotopic expression of a normal ND4 may be the initial step in a gene-based treatment for this blinding disorder

Keywords: 419 gene transfer/gene therapy • 487 neuro-ophthalmology: optic nerve • 475 mitochondria 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×